Results 181 to 190 of about 34,204 (221)

PAX5 functions as a tumor suppressor by RB-E2F-mediated cell cycle arrest in Kaposi sarcoma-associated herpesvirus-infected primary effusion lymphoma. [PDF]

Neoplasia
Goto H, Kariya R, Kudo E, Katano H, Okada S.   +4 more
europepmc   +1 more source

Monomorphic T-cell post-transplant lymphoproliferative disorder with features of HHV8-negative primary effusion lymphoma: an autopsy case and review of the literature. [PDF]

Med Mol Morphol
Hosaka N, Hashimura M, Mugitani A, Hamaguchi M, Kubo Y, Nakatsuka SI.   +5 more
europepmc   +1 more source

Pacritinib inhibits proliferation of primary effusion lymphoma cells and production of viral interleukin-6 induced cytokines. [PDF]

Sci Rep
Wu Y, Wang V, Yarchoan R.
europepmc   +1 more source

Body Cavity Primary Effusion Lymphoma [PDF]

, 2020
openaire   +1 more source

5-AZA Upregulates SOCS3 and PTPN6/SHP1, Inhibiting STAT3 and Potentiating the Effects of AG490 against Primary Effusion Lymphoma Cells. [PDF]

Curr Issues Mol Biol
Di Crosta M, Arena A, Benedetti R, Gilardini Montani MS, Cirone M.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Primary Effusion Lymphoma/Extracavitary Effusion Lymphoma

Pathology Case Reviews, 2012
AbstractPrimary effusion lymphoma (PEL), and its solid counterpart, extracavitary PEL, is a rare, but unique, clinicopathologic entity, which is pathogenetically related to infection with the gamma herpesvirus, Kaposi sarcoma herpesvirus/human herpes virus 8.
Amy Lo, Amy Chadburn
openaire   +1 more source

Primary effusion lymphoma

Current Opinion in Pulmonary Medicine, 2017
To summarize the current epidemiology, management, and outcomes of primary effusion lymphoma (PEL) and highlight possible future research efforts.Cyclophosphamide, doxorubicin, vincristine, prednisone-based chemotherapy regimens alone or in combination with immunomodulatory agents (e.g., lenalidomide), or proteasome inhibitors (e.g., bortezomib), or ...
Nivedita, Arora, Arjun, Gupta, Navid, Sadeghi   +2 more
openaire   +2 more sources

Daratumumab in Primary Effusion Lymphoma

New England Journal of Medicine, 2018
Daratumumab in Primary Effusion Lymphoma In primary effusion lymphoma, a herpesvirus 8 (HHV-8)–associated neoplasm that is most common in HIV-coinfected patients, cells often express CD38.
Nirav N. Shah, Arun K. Singavi, Alexandra Harrington   +2 more
openaire   +1 more source

Plasmablastic Lymphoma and Primary Effusion Lymphoma

2019
Plasmablastic lymphoma (PBL) and primary effusion lymphoma (PEL) are rare CD20-negative variants of diffuse large B-cell lymphoma. Both conditions were initially described in patients with underlying HIV infection, but cases of PBL and PEL have been more recently diagnosed in other immunocompromised states and in immunocompetent individuals.
Thomas A. Guerrero-Garcia, Jorge J. Castillo   +1 more
openaire   +1 more source

Extracavitary Primary Effusion Lymphoma of the Anorectum

Clinical Lymphoma and Myeloma, 2005
We report a case of an extracavitary primary effusion lymphoma occurring in the anorectum of a patient with advanced acquired immune deficiency syndrome. The morphology, null cell immunophenotype, and acquisition of plasma cell markers in this case are typical of the so-called solid variant of primary effusion lymphoma. Lymphoma cells in this case were
Liron, Pantanowitz, Zhao, Wu, Bruce J, Dezube, German, Pihan   +3 more
openaire   +2 more sources